Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as registration number 188062-50-2, is a potent HIV medication. It inhibits the replication of the human immunodeficiency virus (HIV) by preventing the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, enabling the virus to integrate its genetic material into the host's DNA. Abaca

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor employed in the therapy of human immunodeficiency virus infection. Its pharmacological properties involve the competitive inhibition of reverse transcriptase, an enzyme crucial for HIV replication. Abacavir sulfate is a derivative that undergoes modification to its active form, carbo

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. Top-rated global API manufacturer and supplier provides a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and c

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor administered in the treatment of human immunodeficiency virus disease. Its therapeutic properties rely on the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a derivative that undergoes transformation to its active form, c

read more

The Premier Nutraceutical API Supplier

India has firmly established itself as a global hub for dietary supplement ingredient manufacturing, particularly in the realm of Active Pharmaceutical Ingredients (active ingredients). Numerous local firms specialize in the custom synthesis of natural health APIs, serving both the domestic market and exporting globally. These firms boast advanced

read more